Summit Therapeutics (SMMT) Debt Ratio (2022 - 2024)
Summit Therapeutics (SMMT) has disclosed Debt Ratio for 4 consecutive years, with 0.57 as the latest value for Q1 2024.
- For the quarter ending Q1 2024, Debt Ratio rose 44.19% year-over-year to 0.57, compared with a TTM value of 0.57 through Mar 2024, up 44.19%, and an annual FY2023 reading of 0.49, down 33.83% over the prior year.
- Debt Ratio was 0.57 for Q1 2024 at Summit Therapeutics, up from 0.49 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.74 in Q4 2022 and bottomed at 0.22 in Q1 2022.
- Average Debt Ratio over 3 years is 0.44, with a median of 0.42 recorded in 2023.
- Peak annual rise in Debt Ratio hit 82.37% in 2023, while the deepest fall reached 33.83% in 2023.
- Year by year, Debt Ratio stood at 0.74 in 2022, then plummeted by 33.83% to 0.49 in 2023, then rose by 14.8% to 0.57 in 2024.
- Business Quant data shows Debt Ratio for SMMT at 0.57 in Q1 2024, 0.49 in Q4 2023, and 0.42 in Q2 2023.